Publication | Closed Access

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

ThrombopoiesisThrombosisVenous ThrombosisCardiovascular DiseaseHematologySurgeryPharmacotherapyVenous ThromboembolismDose Escalation StudyPlatelet AntagonistMedicineAnticoagulantOrthopaedic Surgery